ImmuCell (ICCC) announced that it is initiating Investigational Product use of Re-Tain. The company intends to use this opportunity to test market acceptance of the product through a controlled launch. This initiative also helps the company utilize available inventory before shelf-life expiration. This opportunity is not expected to generate significant revenue or profit.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICCC:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue